Bioceres Crop Solutions (NASDAQ:BIOX) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Bioceres Crop Solutions (NASDAQ:BIOX) from a hold rating to a sell rating in a research report released on Saturday.

Several other analysts have also recently commented on BIOX. Canaccord Genuity Group dropped their target price on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a research report on Friday, January 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $4.00.

Bioceres Crop Solutions Stock Performance

BIOX stock opened at $0.56 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.90 and a quick ratio of 0.69. The company has a 50 day moving average price of $0.57 and a 200 day moving average price of $1.20. Bioceres Crop Solutions has a fifty-two week low of $0.35 and a fifty-two week high of $5.18. The stock has a market capitalization of $35.28 million, a PE ratio of -0.15 and a beta of 0.53.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.15). Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%.The company had revenue of $73.67 million during the quarter, compared to the consensus estimate of $104.55 million. Analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors and hedge funds have recently made changes to their positions in BIOX. Bank of America Corp DE raised its position in shares of Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after acquiring an additional 5,339 shares during the last quarter. Ardsley Advisory Partners LP grew its holdings in shares of Bioceres Crop Solutions by 4.7% in the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after buying an additional 45,000 shares during the period. Jane Street Group LLC acquired a new position in shares of Bioceres Crop Solutions in the 2nd quarter valued at $202,000. Finally, PDT Partners LLC grew its holdings in shares of Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after buying an additional 10,449 shares during the period. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.